|
|
|
|
GMMMG Consultations |
|
|
On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below. Due to the COVID-19 outbreak all active GMMMG consultations were temporarily suspended in April. The active consultations have now been re-opened; please see below for the new end dates. Every effort has been made to allow sufficient time for appropriate clinical input to these documents, but if you foresee any problems or have any questions please email nuth.enquires.gmmmg@nhs.net |
|
|
Title |
Information |
Feedback |
End date |
|
|
89 |
On behalf of the GMMMG Formulary and Managed Entry Subgroup, an updated Greater Manchester Joint Wound Care Formulary is in development. Adoption of the updated formulary is underway within GM Trusts. We now seek the comments on this draft from primary care and community services. This consultation period is open until 5pm Friday 10th July 2020 |
5pm Friday |
||
|
|
|
|
|
|
|
88 |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide shared care protocol for Azathioprine for IBD in paediatrics is in development. We now seek comments on this draft. This consultation period is open until 5pm on Monday 29th June 2020. |
5pm Monday |
||
|
87 |
PaGDSG - SCP for Ethinylestradiol and estradiol for the induction of delayed puberty |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide shared care protocol for Ethinylestradiol and estradiol for the induction of delayed puberty is in development. We now seek comments on this draft. This consultation period is open until 5pm on Monday 29th June 2020. |
5pm Monday |
|
|
86 |
PaGDSG - SCP for mycophenolate for interstitial lung disease |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide Shared Care Protocol for mycophenolate for interstitial lung disease is in development. We now seek the comments on this draft. This consultation period is open until 5pm Friday 29th May 2020. |
5pm Friday |
|
|
85 |
PaGDSG - SCP for Amiodarone for Severe Rhythm Disorder in Adults |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an new Greater Manchester wide Shared Care Protocol for Amiodarone for Severe Rhythm Disorder in Adults is in development. We now seek the comments on this draft. This consultation period is open until 5pm Friday 29th May 2020. |
5pm Friday |
|
|
84 |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide Shared Care Protocol for methotrexate for interstitial lung disease is in development. We now seek the comments on this draft. This consultation period is open until 5pm Friday 29th May 2020 |
5pm Friday |
||
|
83 |
PaGDSG - SCP for hydroxychloroquine for interstitial lung disease |
On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester wide Shared Care Protocol for hydroxychloroquine for interstitial lung disease is in development. We now seek the comments on this draft. This consultation period is open until 5pm Friday 29th May 2020. |
5pm Friday |
|
|
82 |
FMESG actions from February 2020 meeting [link removed - consultation closed] |
The following FMESG actions for February 2020 [link removed - consultation closed] have been proposed. We now seek comments [link removed - consultation closed] on these proposals. This consultation is open until 5pm on Monday 18th May 2020 |
Feedback Form |
5pm Monday |
<< Back
